ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2015 American Transplant Congress

    Inside Out Autologous Neo-Liver Fabrication

    P. Than, C. Davis, M. Findlay, W. Liu, T. Le, S. Khong, M. Melcher, G. Gurtner.

    Surgery, Stanford University School of Medicine, Stanford, CA.

    Background: Creation of patient-specific replacement organs promises to address major shortcomings in transplantation. We previously described an approach to fabricate autologous, vascularized neo-organs by using…
  • 2015 American Transplant Congress

    Consideration of the Futility of Transplant: 50% Mortality at 5 Years

    S. Asrani, G. Saracino, J. O'Leary, G. Klintmalm, J. Trotter.

    Baylor University Medical Center, Dallas, TX.

    Introduction: Transplant recipients are globally sicker at the time of liver transplantation (LT) in the current era. We sought to devise and validate a model…
  • 2015 American Transplant Congress

    Vitamin D Deficiency in Liver Transplant Recipients: Prevalence, Risk Factors, and Outcomes

    T. Joson, T. Schiano, A. Mehrotra.

    Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

    Vitamin D is known to be immunomodulatory, and its deficiency is associated with multiple chronic health problems in the general population. The objective of this…
  • 2015 American Transplant Congress

    Listing for Liver Transplantation of Patients With Hepatocellular Carcinoma Using the Extended Toronto Criteria; an Intention-to-Treat Analysis

    G. Sapisochin, N. Goldaracena, J. Laurence, A. Barbas, M. Dib, A. Ghanekar, M. Selzner, L. Lilly, I. McGilvray, M. Cattral, E. Renner, P. Greig, D. Grant.

    Multi-Organ Transplant, Toronto General Hospital. University of Toronto, Toronto, ON, Canada.

    The role of liver transplantation for patients whose HCC exceeds Milan criteria remains controversial. At the University of Toronto, we have reported survivals of a…
  • 2015 American Transplant Congress

    Are We Missing Cardiovascular Disease in Children Awaiting Liver Transplant?

    C. Villa,1 E. Hahn,1 J. Bucuvalas,2 K. Campbell,2 R. Hirsch,1 M. Lake,2 A. Lorts.1

    1Heart Institute, Cincinnati Childrens Hospital, Cincinnati, OH; 2Pediatric Liver Care Center, Cincinnati Childrens Hospital, Cincinnati, OH.

    Background: Cirrhotic cardiomyopathy, characterized by low systemic vascular resistance, is increasingly recognized as a complication of end stage liver disease. Yet optimal strategies to screen…
  • 2015 American Transplant Congress

    Pediatric Liver Transplantation for Metabolic Diseases: Analysis of Children's Hospital of Pittsburgh (CHP) and United Network for Organ Sharing (UNOS) Databases

    A. Ganoza, B. Shneider, R. Sindhi, K. Soltys, G. Bond, G. Vockley, Q. Sun, G. Mazariegos.

    Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

    Purpose: To analyze long term patient survival outcomes after primary LTx for metabolic disease in children <21 years at CHP (1981-2014) and the multi-center UNOS…
  • 2015 American Transplant Congress

    Iron Deficiency Impairs Regulatory T Cell Induction

    R. Danger,1 E. Bonaccorsi-Riani,1 E. Kodela,1 H. Collins,2 R. Hider,3 M. Martínez-Llordella,1 A. Sánchez-Fueyo.1

    1Department of Liver Sciences, Faculty of Life Sciences & Medicine, MRC Transplant Centre, King's College London, London, United Kingdom; 2Department of Immunology, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; 3Institute of Pharmaceutical Science, King's College London, London, United Kingdom.

    In a recent clinical trial of immunosuppression withdrawal in adult liver transplant recipients, operational tolerance was associated with development of a transient lymphocyte infiltration rich…
  • 2015 American Transplant Congress

    Ischemic Cholangiopathy Following Liver Transplantation from Donation After Circulatory Death Donors: Role of Tissue Plasminogen Activator Flush

    C. Kubal,1 R. Mangus,1 J. Fridell,1 M. Wingler,2 S. Nagai,1 B. Ekser,1 J. Tector.1

    1Department of Surgery, Indiana University, Indianapolis, IN; 2Indiana Organ Procurement Organization, Indianapolis, IN.

    Background: Formation of microthrombi within the peribiliary arterial plexus causing necrosis of biliary epithelium may be responsible for ischemic cholangiopathy (IC) after donation after circulatory…
  • 2015 American Transplant Congress

    Impact of Pretransplant Sarcopenia and Sequential Changes in Sarcopenic Parameters After Living Donor Liver Transplantation

    T. Kaido,1 Y. Tamai,2 K. Ogawa,1 Y. Fujimoto,1 A. Mori,1 H. Okajima,1 N. Inagaki,2 S. Uemoto.1

    1Hepato-Biliary-Pancreatic and Transplant Surgery, Kyoto University, Kyoto, Japan; 2Metabolism and Clinical Nutrition, Kyoto University Hospital, Kyoto, Japan.

    The present study investigated the impact of pretransplant sarcopenia on survival and sequential changes in sarcopenic parameters in patients undergoing living donor liver transplantation (LDLT).…
  • 2015 American Transplant Congress

    HCV Treatment in Liver Transplantation: Changes in Center Attitudes and Practices in the DAA Era

    A. Shaffer, A. Cash, S. Anjum, D. Segev, C. Durand.

    Surgery, Johns Hopkins University, Baltimore, MD.

    Chronic hepatitis C virus infection (HCV) is the leading indication for liver transplantation (LT) in the US. Safe and effective directly acting antivirals (DAAs) are…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences